[Molecular mechanisms of myocardial anti-ischemic protection by pharmacologic agents (a review of the literature)].
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D002316:Cardiotonic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002462:Cell Membrane / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy* / Q000378:metabolism; D004247:DNA / Q000378:metabolism; D004734:Energy Metabolism / Q000187:drug effects; D006321:Heart / Q000187:drug effects*; D008929:Mitochondria, Heart / Q000187:drug effects / Q000528:radiation effects; D008967:Molecular Biology; D010084:Oxidation-Reduction / Q000187:drug effects; D012313:RNA / Q000378:metabolism; D014466:Ultraviolet Rays; D014810:Vitamin E / Q000494:pharmacology / Q000627:therapeutic use
D002316:Cardiotonic Agents; D014810:Vitamin E; D012313:RNA; D000255:Adenosine Triphosphate; D004247:DNA
Molekuliarnye mekhanizmiy protivoishemicheskoĭ zashchity miokarda farmakologicheskimi sredstvami (obzor literatury).